These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27586181)

  • 1. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
    Anantharamaiah GM; Garber DW; White CR
    Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.
    Nayyar G; Handattu SP; Monroe CE; Chaddha M; Datta G; Mishra VK; Keenum TD; Palgunachari MN; Garber DW; Anantharamaiah GM
    Atherosclerosis; 2010 Dec; 213(2):449-57. PubMed ID: 21030022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E mimetics and cholesterol-lowering properties.
    Sharifov OF; Nayyar G; Garber DW; Handattu SP; Mishra VK; Goldberg D; Anantharamaiah GM; Gupta H
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):371-81. PubMed ID: 22149316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.
    Datta G; Chaddha M; Garber DW; Chung BH; Tytler EM; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
    Biochemistry; 2000 Jan; 39(1):213-20. PubMed ID: 10625496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
    Sharifov OF; Nayyar G; Ternovoy VV; Palgunachari MN; Garber DW; Anantharamaiah G; Gupta H
    Innate Immun; 2014 Nov; 20(8):867-80. PubMed ID: 24323453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo.
    Datta G; Garber DW; Chung BH; Chaddha M; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
    J Lipid Res; 2001 Jun; 42(6):959-66. PubMed ID: 11369804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
    Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
    Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
    Amar MJ; D'Souza W; Turner S; Demosky S; Sviridov D; Stonik J; Luchoomun J; Voogt J; Hellerstein M; Sviridov D; Remaley AT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):634-41. PubMed ID: 20484557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.
    Anantharamaiah GM; Garber DW; Goldberg D; Morrel E; Datta G; Palgunachari MN; Register TC; Appt SE; White CR
    J Lipid Res; 2018 Nov; 59(11):2075-2083. PubMed ID: 30201630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.
    Datta G; Chaddha M; Handattu SP; Palgunachari MN; Nayyar G; Garber DW; Gupta H; White CR; Anantharamaiah GM
    Adv Exp Med Biol; 2010; 660():1-4. PubMed ID: 20221865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia.
    Wolkowicz P; White CR; Anantharamaiah GM
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33922449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E mimetic Peptide dramatically lowers plasma cholesterol and restores endothelial function in watanabe heritable hyperlipidemic rabbits.
    Gupta H; White CR; Handattu S; Garber DW; Datta G; Chaddha M; Dai L; Gianturco SH; Bradley WA; Anantharamaiah GM
    Circulation; 2005 Jun; 111(23):3112-8. PubMed ID: 15939819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).
    Datta G; White CR; Dashti N; Chaddha M; Palgunachari MN; Gupta H; Handattu SP; Garber DW; Anantharamaiah GM
    Atherosclerosis; 2010 Jan; 208(1):134-41. PubMed ID: 19656510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
    Davidson WS; Lund-Katz S; Johnson WJ; Anantharamaiah GM; Palgunachari MN; Segrest JP; Rothblat GH; Phillips MC
    J Biol Chem; 1994 Sep; 269(37):22975-82. PubMed ID: 8083197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.
    Handattu SP; Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Mishra VK; Datta G; Anantharamaiah GM
    Atherosclerosis; 2013 Mar; 227(1):58-64. PubMed ID: 23159231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.
    Garber DW; Handattu S; Aslan I; Datta G; Chaddha M; Anantharamaiah GM
    Atherosclerosis; 2003 Jun; 168(2):229-37. PubMed ID: 12801605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides as Therapeutic Agents for Atherosclerosis.
    White CR; Palgunachari M; Wolkowicz P; Anantharamaiah GM
    Methods Mol Biol; 2022; 2419():89-110. PubMed ID: 35237960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.
    Ditiatkovski M; D'Souza W; Kesani R; Chin-Dusting J; de Haan JB; Remaley A; Sviridov D
    PLoS One; 2013; 8(7):e68802. PubMed ID: 23874769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing structure and function of VLDL by synthetic amphipathic helical peptides.
    Chung BH; Palgunachari MN; Mishra VK; Chang CH; Segrest JP; Anantharamaiah GM
    J Lipid Res; 1996 May; 37(5):1099-112. PubMed ID: 8725161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.